Prophylactic pancreatic stent in addition to rectal indomethacin effective for preventing post-ERCP pancreatitis
Endoscopic retrograde cholangiopancreatography (ERCP) is a valuable diagnostic and therapeutic procedure, but it comes with the risk of pancreatitis, particularly in high-risk patients. A recent randomized trial assessed two preventive strategies—rectal indomethacin alone versus the combination of indomethacin plus a prophylactic pancreatic stent.
This study was published in the journal Lancet by Prof B Joseph E. and colleagues. The study aimed to evaluate efficacy and safety, providing valuable insights for enhancing post-ERCP patient care.Therandomized non-inferiority trial involving 1950 high-risk patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), researchers evaluated the efficacy of two preventive strategies: rectal indomethacin alone versus the combination of indomethacin plus a prophylactic pancreatic stent.
The primary outcome, post-ERCP pancreatitis incidence, was 14.9% with indomethacin alone and 11.3% with the combination, resulting in a risk difference of 3.6% (95% CI 0.6–6.6; p=0.18 for non-inferiority).
However, a post-hoc analysis revealed the superiority of the combination strategy (p=0.011).
Safety outcomes, including serious adverse events, intensive care unit admission, and hospital length of stay, did not significantly differ between the two groups.
The trial concludes that, for high-risk patients undergoing ERCP, the strategy of using rectal indomethacin alone was not as effective as combining indomethacin with prophylactic pancreatic stent placement. These findings advocate for the adoption of a comprehensive approach, emphasizing the role of prophylactic stent placement in addition to indomethacin administration for optimal prevention of post-ERCP pancreatitis in high-risk patients.
Reference:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.